Published on in Vol 21, No 1 (2019): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/10004, first published .
An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study

An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study

An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study

Lina Maria Matthies   1 * ;   Florin-Andrei Taran   2 * ;   Lucia Keilmann   1 ;   Andreas Schneeweiss   1 ;   Elisabeth Simoes   3 ;   Andreas D Hartkopf   2 ;   Alexander N Sokolov   3, 4 ;   Christina B Walter   2 ;   Nina Sickenberger   1 ;   Stephanie Wallwiener   1 ;   Manuel Feisst   5 ;   Paul Gass   6 ;   Michael P Lux   6 ;   Florian Schuetz   1 ;   Peter A Fasching   6 ;   Christof Sohn   1 ;   Sara Y Brucker   3 ;   Joachim Graf   3, 4 * ;   Markus Wallwiener   1 *

1 Hospital for General Obstetrics and Gynecology, Gynecologic Oncology, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany

2 Department of Women’s Health, University Hospital Tübingen, Tübingen, Germany

3 Research Institute for Women’s Health, Department of Women’s Health, University Hospital Tübingen, Tübingen, Germany

4 Section of Midwifery Science, Institute for Health Sciences, University Hospital Tübingen, Tübingen, Germany

5 Institute for Medical Biometry and Informatics, University Hospital Heidelberg, Heidelberg, Germany

6 Department of Gynecology and Obstetrics, University Breast Center Franconia, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Erlangen, Germany

*these authors contributed equally

Corresponding Author:

  • Markus Wallwiener
  • Hospital for General Obstetrics and Gynecology
  • Gynecologic Oncology, National Center for Tumor Diseases
  • University Hospital Heidelberg
  • Im Neuenheimer Feld 440
  • Heidelberg, 69120
  • Germany
  • Phone: 49 (0)6221 5636956
  • Email: markus.wallwiener@gmail.com